0
Education, Teaching, and Quality Improvement |

Leading Practice in Venous Thromboembolism Prophylaxis

Eduardo Sad, MD; Maria Chiara Chindamo; Fernando Afonso, MD; Oneide Silva; Kelviane Baêta; Wagner Schiavinni; Jerffeson Dias
Author and Funding Information

Critical Care, Hospital Barra Dor, Belo Horizonte, Minas Gerais, Brazil


Chest. 2014;146(4_MeetingAbstracts):546A. doi:10.1378/chest.1995138
Text Size: A A A
Published online

Abstract

SESSION TITLE: Quality & Clinical Improvement II

SESSION TYPE: Original Investigation Slide

PRESENTED ON: Tuesday, October 28, 2014 at 11:00 AM - 12:15 PM

PURPOSE: The implementation of VTE prevention protocol is considered effective at reducing the risk of events in hospitalized patients. The aims of our study are to present the assistance flow, assessment and monitoring tools, and the efficacy rate of VTE prophylaxis protocols.

METHODS: A protocol for prevention of VTE was developed based on the Safety Zone Program, updated in accordance with the Guidelines of the 9th ACCP. We established a Multidisciplinary Commission to assign the elaboration of the institutional protocol, promote learning actions with medical staff, conduct periodic audits, monitor results, and establish communication strategies and participation of patients and families in measures of thromboprophylaxis. The protocol monitoring is focused on the participation of the clinical pharmacist responsible for assessing risk of VTE within 24-48h of admission, reassessing every 48h and intervening in case of non-compliance. In intensive care units, VTE risk is evaluated through a daily checklist to assess the adequacy of prophylaxis using a Hospital Management Program, EPIMED Monitor. The compliance is also reevaluated by the pharmacist at least every 48h. Medical professionals with low adhesion to the program receive personal orientation from the Committee. The Protocol includes control of correct use of mechanical devices and early ambulation stimulation (use of “Daily walking diary” and rehabilitation program by physiotherapists). All cases of VTE in hospitalized patients and readmissions within 30 days for VTE were analyzed.

RESULTS: We evaluated 5819 patients between Oct 2012 and Sep 2013 and results of performance markers were the following: 1)Mean proportion of patients with risk assessment within the first 24h in ICU: 95%; 2)Mean proportion of clinical patients with indication, use and monitoring of therapy, according to institutional protocol: 94%; 3)Mean proportion of patients with surgery of moderate and high risk who received recommended treatment: 87%; 4)Mean proportion of surgical and clinical patients that appropriately used mechanical methods: 95%; 5) Incidence of DVT: 0.3%; 6)Incidence of PE: 0.05%; 7)Mortality from VTE: 0.03%; and 8) Readmission within 30 days for VTE: 0.02%.

CONCLUSIONS: A systematic risk assessment tool is important to improve knowledge and adhesion to thromboprophylaxis, which associated to regular analysis of VTE cases leads to an improvement in medical care.

CLINICAL IMPLICATIONS: A VTE prophylaxis program effectively reduces events in hospitalized patients.

DISCLOSURE: The following authors have nothing to disclose: Eduardo Sad, Maria Chiara Chindamo, Fernando Afonso, Oneide Silva, Kelviane Baêta, Wagner Schiavinni, Jerffeson Dias

No Product/Research Disclosure Information


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543